Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000936453 | SCV001082221 | likely benign | Neurofibromatosis, type 1 | 2024-05-03 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002319602 | SCV001177836 | uncertain significance | Hereditary cancer-predisposing syndrome; Cardiovascular phenotype | 2019-01-21 | criteria provided, single submitter | clinical testing | The c.289-4T>G intronic alteration consists of a T to G substitution 4 nucleotides before coding exon 4 in the NF1 gene. Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |